The Hair Loss Encyclopedia

Search

for
Search:

GlossaryEverolimus

medication that inhibits mTOR pathway, used in cancer treatment

Everolimus is a medication that inhibits the mTOR (mammalian target of rapamycin) pathway, which is crucial for cell growth and proliferation. It is commonly used in cancer treatment to slow tumor growth and in organ transplantation to prevent rejection. Additionally, it has applications in treating certain rare diseases and conditions like tuberous sclerosis complex.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 79 results

Gingival Hyperplasia Secondary to Everolimus Therapy

research Gingival Hyperplasia Secondary to Everolimus Therapy

January 2010 in “Actas Dermo-Sifiliográficas”

A woman developed thick gums from everolimus treatment after a kidney transplant.

Cutaneous Toxicities From Transplantation-Related Medications

research Cutaneous Toxicities From Transplantation-Related Medications

14 citations , April 2017 in “American Journal of Transplantation”

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

research Trapped in the Hypoglycemia Loop: A Case Study of Malignant Insulinoma

May 2025 in “Journal of the ASEAN Federation of Endocrine Societies”

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Aortocaval Paraganglioma in Von Hippel-Lindau Disease

research Aortocaval Paraganglioma in Von Hippel-Lindau Disease

May 2025 in “Journal of the ASEAN Federation of Endocrine Societies”

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Contact Allergic Dermatitis to Quinine in an Anti-Hair Loss Lotion

research Contact Allergic Dermatitis to Quinine in an Anti-Hair Loss Lotion

January 2010 in “Actas Dermo-Sifiliográficas”

A woman was allergic to quinine in her anti-hair loss lotion.

View more "everolimus" in research →

Community Join

0 / 0 results

— no results